Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
PPAR2265 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A24563 | 22748277 | Atherosclerosis | Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. | 2012 | Details |
A24566 | 22742931 | J Gastroenterol Hepatol | Functional role of peroxisome-proliferator-activated receptor γ in hepatocellular carcinoma. | 2012 | Details |
A24628 | 22674675 | Phytother Res | Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet. | 2012 | Details |
A24708 | 22576368 | Mol Med | Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice. | 2012 | Details |
A24732 | 22551412 | J Med Food | Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis. | 2012 | Details |
A24776 | 22509083 | World J Gastroenterol | Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. | 2012 | Details |
A24806 | 22469867 | Int J Mol Med | Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice. | 2012 | Details |
A24824 | 22464551 | Nutrition | Non-alcoholic fatty liver disease in children now: lifestyle changes and pharmacologic treatments. | 2012 | Details |
A24825 | 22462240 | J Tradit Chin Med | Dangfei liganning capsules attenuate the susceptibility of rat nonalcoholic fatty liver to carbon tetrachloride toxicity. | 2011 | Details |
A24827 | 22458550 | Nutr Metab (Lond) | Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6 J mice fed a high-fat diet via fatty acid oxidation. | 2012 | Details |
A24832 | 22450341 | Hormones (Athens) | Adiponectin: regulation of its production and its role in human diseases. | 2012 | Details |
A24861 | 22425624 | J Hepatol | Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. | 2012 | Details |
A24875 | 22414768 | J Hepatol | Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2012 | Details |
A24915 | 22364184 | J Agric Food Chem | Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways. | 2012 | Details |
A24950 | 22326465 | J Hepatol | Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. | 2012 | Details |
A24979 | 22285877 | Magn Reson Imaging | Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging. | 2012 | Details |
A25035 | 22227283 | Prev Med | Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling. | 2011 | Details |
A25045 | 22219597 | World J Gastroenterol | Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. | 2011 | Details |
A25049 | 22215515 | Toxicol Pathol | Mice deficient in glycerol-3-phosphate acyltransferase-1 have a reduced susceptibility to liver cancer. | 2012 | Details |
A25113 | 22160635 | Dig Dis Sci | Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD. | 2011 | Details |
A25133 | 22152320 | Zhonghua Gan Zang Bing Za Zhi | [Effects of telmisartan on nonalcoholic steatohepatitis rat model by activating peroxisome proliferator-activated receptor r]. | 2011 | Details |
A25177 | 22110479 | Exp Diabetes Res | Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice. | 2011 | Details |
A25199 | 22098164 | J Gastroenterol Hepatol | Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export. | 2012 | Details |
A25206 | 22094893 | Curr Top Microbiol Immunol | Contribution of the intestinal microbiota to human health: from birth to 100 years of age. | 2013 | Details |
A25209 | 22093454 | Liver Int | Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction. | 2011 | Details |
A25222 | 22082335 | Chem Res Toxicol | Glutathione-deficient mice are susceptible to TCDD-Induced hepatocellular toxicity but resistant to steatosis. | 2011 | Details |
A25241 | 22056763 | Biochim Biophys Acta | Roles of PPARs in NAFLD: potential therapeutic targets. | 2011 | Details |
A25283 | 22008843 | Food Funct | The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. | 2011 | Details |
A25287 | 21994008 | Hepatology | Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. | 2012 | Details |
A25342 | 21946918 | Mol Med Rep | Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet. | 2011 | Details |
A25343 | 21946149 | Exp Mol Pathol | Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis. | 2011 | Details |
A25349 | 21939732 | Mol Cell Endocrinol | PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population. | 2011 | Details |
A25351 | 21936721 | Scand J Gastroenterol | Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice. | 2011 | Details |
A25360 | 21929649 | J Gastroenterol Hepatol | Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. | 2012 | Details |
A25373 | 21911890 | Ann Hepatol | Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet. | 2011 | Details |
A25508 | 21742296 | Clin Res Hepatol Gastroenterol | Liver fibrogenesis and metabolic factors. | 2011 | Details |
A25528 | 21745271 | Liver Int | Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. | 2011 | Details |
A25542 | 21733354 | Chang Gung Med J | Disrupted hepatic adiponectin signaling impairs liver regeneration of steatotic rats. | 2011 | Details |
A25572 | 21703185 | J Hepatol | Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway. | 2011 | Details |
A25629 | 21626400 | J Physiol Biochem | Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes. | 2011 | Details |
A25630 | 21624329 | Zhonghua Yu Fang Yi Xue Za Zhi | [Effects of soybean isoflavone on liver lipid metabolism in nonalcoholic fatty liver rats]. | 2011 | Details |
A25639 | 21616061 | Biochem Biophys Res Commun | Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease. | 2011 | Details |
A25696 | 21530275 | Bioorg Med Chem | Structure-based design, synthesis, and nonalcoholic steatohepatitis (NASH)-preventive effect of phenylpropanoic acid peroxisome proliferator-activated receptor (PPAR) α-selective agonists. | 2011 | Details |
A25697 | 21529810 | Atherosclerosis | PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH. | 2011 | Details |
A25721 | 21507897 | FASEB J | Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. | 2011 | Details |
A25774 | 21474829 | Arterioscler Thromb Vasc Biol | Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice. | 2011 | Details |
A25777 | 21470125 | Curr Pharm Biotechnol | Methodologies for investigating natural medicines for the treatment of nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
A25779 | 21464822 | Lab Invest | Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice. | 2011 | Details |
A25780 | 21463618 | Eur J Pharmacol | A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance. | 2011 | Details |
A25797 | 22813407 | Diabetes Metab Syndr | Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population. | 2012 | Details |
A25799 | 21448953 | J Magn Reson Imaging | Effect of disease progression on liver apparent diffusion coefficient values in a murine model of NASH at 11.7 Tesla MRI. | 2011 | Details |
A25845 | 21401612 | J Pharm Pharmacol | Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. | 2011 | Details |
A25859 | 21382273 | J Biol Regul Homeost Agents | Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. | 2011 | Details |
A25860 | 21382219 | Br J Nutr | Neonatal exposure to genistein ameliorates high-fat diet-induced non-alcoholic steatohepatitis in rats. | 2011 | Details |
A25861 | 21382165 | Liver Int | A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet. | 2011 | Details |
A25875 | 21364286 | J Clin Invest | Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2. | 2011 | Details |
A25897 | 21346097 | J Nutr | PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. | 2011 | Details |
A25905 | 21339203 | Gut | The role of apolipoprotein A5 in non-alcoholic fatty liver disease. | 2011 | Details |
A25920 | 21327395 | Cell Tissue Res | Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation. | 2011 | Details |
A25921 | 21325464 | J Clin Endocrinol Metab | Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. | 2011 | Details |
A25955 | 21269482 | Lipids Health Dis | Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats. | 2011 | Details |
A25976 | 21246004 | World J Gastroenterol | Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. | 2011 | Details |
A25977 | 21245286 | Drug Metab Dispos | Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. | 2011 | Details |
A26005 | 21216282 | Biochim Biophys Acta | Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease. | 2011 | Details |
A26032 | 21184786 | J Hepatol | Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. | 2010 | Details |
A26058 | 21155004 | World J Gastroenterol | Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. | 2010 | Details |
A26070 | 21145833 | J Hepatol | Direct effects of iodothyronines on excess fat storage in rat hepatocytes. | 2010 | Details |
A26086 | 21128245 | Int J Cancer | Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. | 2011 | Details |
A26089 | 21126079 | J Agric Food Chem | Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit. | 2010 | Details |
A26120 | 21068129 | Gut | Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. | 2010 | Details |
A26121 | 21067942 | Trends Endocrinol Metab | Fructose induced lipogenesis: from sugar to fat to insulin resistance. | 2010 | Details |
A26157 | 20981217 | Gut Liver | Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. | 2010 | Details |
A26169 | 20965162 | Eur J Pharmacol | The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats. | 2010 | Details |
A26183 | 20943079 | Zhonghua Gan Zang Bing Za Zhi | [Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease]. | 2010 | Details |
A26190 | 20938947 | Hepatology | Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. | 2010 | Details |
A26196 | 20929443 | Clin Sci (Lond) | Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. | 2011 | Details |
A26202 | 20890895 | Hepatology | Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. | 2010 | Details |
A26226 | 20868235 | Biol Chem | Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice. | 2010 | Details |
A26245 | 20842602 | Swiss Med Wkly | Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. | 2010 | Details |
A26252 | 20836990 | Biochem Biophys Res Commun | Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice. | 2010 | Details |
A26257 | 20825652 | BMC Gastroenterol | Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study. | 2010 | Details |
A26259 | 20818807 | World J Gastroenterol | Obstructive sleep apnea syndrome and fatty liver: association or causal link? | 2010 | Details |
A26273 | 20803499 | Hepatology | A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. | 2010 | Details |
A26275 | 20801631 | J Nutr Biochem | An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat. | 2010 | Details |
A26298 | 20687969 | Br J Nutr | The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. | 2010 | Details |
A26301 | 20683463 | Eur J Clin Nutr | Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women. | 2010 | Details |
A26304 | 20675007 | J Hepatol | Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. | 2010 | Details |
A26305 | 20673376 | Br J Nutr | A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: possible implication of the sirtuin pathway. | 2010 | Details |
A26369 | 20579864 | J Nutr Biochem | Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. | 2010 | Details |
A26386 | 20553760 | Prog Lipid Res | Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease. | 2010 | Details |
A26403 | 20509914 | BMC Gastroenterol | Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis. | 2010 | Details |
A26417 | 20492333 | J Gastroenterol Hepatol | Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. | 2010 | Details |
A26476 | 20416398 | Biochim Biophys Acta | Increase of hepatic fat accumulation by liver specific expression of Hepatitis B virus X protein in zebrafish. | 2010 | Details |
A26496 | 20392873 | J Clin Endocrinol Metab | Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease. | 2010 | Details |
A26515 | 20370732 | J Gastroenterol Hepatol | Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis? | 2010 | Details |
A26526 | 20037278 | Korean J Hepatol | Current status of liver disease in Korea: nonalcoholic fatty liver disease. | 2009 | Details |
A26528 | 20357081 | J Nutr | Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. | 2010 | Details |
A26543 | 20236931 | J Biol Chem | Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner. | 2010 | Details |
A26558 | 20206411 | Gastroenterol Hepatol | [Obesity and liver disease]. | 2010 | Details |
A26559 | 20206399 | J Hepatol | Impaired liver regeneration of steatotic rats after portal vein ligation: a particular emphasis on (99m)Tc-DISIDA scintigraphy and adiponectin signaling. | 2010 | Details |